Twitter Linkedin-in

Biologics UK: In-Person

: Speakers

Speakers

21 – 22 March 2022 | London, UK
+ Digital Day: 23 March 2022 | Online
Part of the
Biologics Series
Biologics UK:
In-Person
Oligonucleotide Chemistry & Therapeutics Symposium
Antibody Engineering:
Online
Vaccines Europe:
In-Person
Book Now

Biologics UK: In-Person has now concluded. Please click here for more information on other events within our Biologics Series, taking place throughout the year.

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for Biologics UK: In-Person 2022

Alessandro Sannino

Alessandro Sannino

Senior Expert Science & Technology
Novartis
Alex MacPherson

Alex MacPherson

Senior Principle Scientist
UCB
Ali Tavassoli

Ali Tavassoli

Chief Scientific Officer, Professor
Curve Therapeutics, University of Southampton
Amy Doty

Amy Doty

Associate Principal Scientist
MSD
Andrew Argo

Andrew Argo

Scientist I
Biogen
Angus Sinclair

Angus Sinclair

Senior Vice President, Immuno-Oncology
IGM Biosciences
Anna Hine

Anna Hine

Professor
Aston University
Barbara Hebeis

Barbara Hebeis

Director, Bioassay
AstraZeneca
Colette Johnston

Colette Johnston

Senior Director, Early Discovery
Crescendo Biologics
Dan Bach Kristensen

Dan Bach Kristensen

Principal Scientist , Analytics and Formulation
Symphogen
Daniel Fleischanderl

Daniel Fleischanderl

Head of Upstream Development (Microbial) / Director
Boehringer-Ingelheim
David Humphries

David Humphries

Senior Director, New Modalities and Therapeutics.
UCB
Denice Chan

Denice Chan

Senior Scientist
Cancer Research UK - AstraZeneca Antibody Alliance Laboratory
Denis Drygin

Denis Drygin

Chief Scientific Officer
Regulus Therapeutics
Min Fang

Dilyana Dimova

Data Scientist
Sanofi
Dmitry Samarsky

Dmitry Samarsky

Chief Technology Officer
Sirnaomics
Enkelejda Miho

Enkelejda Miho

Professor
University of Applied Sciences and Arts Northwestern Switzerland
Ernst Weber

Ernst Weber

Head of Molecular Design & Engineering
Bayer AG
Min Fang

Francis Duffieux

Head of Protein Purification and Microbial Fermentation
Sanofi
Francois Bertelli

Francois Bertelli

Head of Platform Development
Avvinity
Gene Liau

Gene Liau

Chief Scientific Officer
Stoke Therapeutics
Harald Kolmar

Harald Kolmar

Professor
Technical University of Darmstadt
Helen Payne

Helen Payne

Senior Scientist, High Throughput Characterisation
GlaxoSmithKline
Min Fang

Hetal Sarvaya

Associate Director, DMPK-BA
AbbVie
Ijeoma Florence Uchegbu

Ijeoma Florence Uchegbu

Professor of Pharmaceutical Nanoscience
University College London
Ilias Jimidar

Ilias Jimidar

Associate Director, Scientific Integration
Janssen
Immanuel Lerner

Immanuel Lerner

Chief Executive Officer
Pepticom
Min Fang

Jeffrey Luo

Associate Scientific Director
Janssen
Joël Richard

Joël Richard

Executive Committee Member - Chief Development Officer
MedInCell
Katerine van Rietschoten

Katerine van Rietschoten

Team Leader - Peptide Chemistry
Bicycle Therapeutics
Katrin Reichel

Katrin Reichel

Senior Data Scientist
Sanofi
Katrina Campbell

Katrina Campbell

Professor
Queen's University Belfast
Keith Foster

Keith Foster

Chief Scientific Officer
Sutura Therapeutics
Kevin McDonnell

Kevin McDonnell

Vice President, Chemistry, US
Bicycle Therapeutics
Kristian Stromgaard

Kristian Stromgaard

Chief Executive Officer/Professor
Avilex Pharma/University of Copenhagen
Laura von Schantz

Laura von Schantz

VP Discovery
Alligator Bioscience AG
Laure Bouchez

Laure Bouchez

Senior Director
Worg Pharma
Mahendra Deonaraian

Mahendra Deonaraian

Chief Executive and Science Officer
Antikor Biopharma Ltd
Manoj Pal

Manoj Pal

Principal Scientist, Analytical & Formulation Development
Ambrx
Marc Vendrell

Marc Vendrell

Professor
University of Edinburgh
Marlon Hinner

Marlon Hinner

Principal Scientist
Roche Pharmaceuticals
Martin Akerman

Martin Akerman

Chief Technology Officer, Co-Founder
Envisagenics
Michael Keller

Michael Keller

Senior Principle Scientist
Roche
Michaela Blech

Michaela Blech

Associate Director of Global Pharmaceutical Development
Boehringer Ingelheim
Min Fang

Min Fang

Senior Scientist
National Institute for Biological Standards and Control
Nagy Habib

Nagy Habib

Founder, Head of R&D
MiNA Therapeutics
Naresh Badgujar

Naresh Badgujar

Associate Principal Scientist
AstraZeneca
Neeraj Agrawal

Neeraj Agrawal

Principal Scientist and Group Leader
Amgen
Neil Birkett

Neil Birkett

Process Development Lead
Crescendo Biologics
Nicholas Mitchell

Nicholas Mitchell

Assistant Professor & Group Leader
University of Nottingham
Min Fang

Nicolas Basse

Head of immuno-oncology cluster
Sanofi
Nigel Davies

Nigel Davies

Principal Scientist
AstraZeneca
Paul Dalby

Paul Dalby

Professor
University College London
Peter Molloy

Peter Molloy

Director of Proteins Science Research
Immunocore
Min Fang

Peter Slavny

Chief Technology Officer
Iontas
Punit Seth

Punit Seth

Senior Vice President
Alnylam Pharmaceuticals
Robin Loving

Robin Loving

Chief Scientific Officer
Salipro Biotech AG
Sarah Lovelock

Sarah Lovelock

UKRI Future Leaders Fellow
University of Manchester
Min Fang

Sebastien Violini

Scientist, Technical Research & Development
Roche Pharmaceuticals
Sergio Mallart

Sergio Mallart

Principle Scientist
Sanofi
Silvia Sonzini

Silvia Sonzini

Associate Principle Scientist
AstraZeneca
Stefan Zielonka

Stefan Zielonka

Associate Director; Protein Engineering & Antibody Technologies
Merck KGaA
Steve Hood

Steve Hood

Senior Scientific Director, Imaging Expertise Networks
GlaxoSmithKline
Steven Grant

Steven Grant

Manager, Biopharm Molecular Discovery
GlaxoSmithKline
Suzanne Bal

Suzanne Bal

Scientist
Merus
Min Fang

Tanja Gaissmaier

Scientist, Potency Skill Center
Boehringer Ingelheim
Tom Brown

Tom Brown

Professor of Nucleic Acid Chemistry
University of Oxford
Tomas Leek

Tomas Leek

Director
AstraZeneca
Trevor Wilkinson

Trevor Wilkinson

Associate Director
AstraZeneca
Wu Su

Wu Su

Team Leader and Director of Medicinal Chemistry
AstraZeneca
Yi Yang

Yi Yang

Lead Scientist
Ferring Pharmaceuticals

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.